Free Trial
→ Tomorrow's Stock of the Day (From The Early Bird) (Ad)tc pixel Free SHW Stock Alerts

Sherwin-Williams (SHW) Financials

Sherwin-Williams logo
$309.18 +2.84 (+0.93%)
Closing price 05/14/2026 03:59 PM Eastern
Extended Trading
$305.95 -3.23 (-1.04%)
As of 04:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Sherwin-Williams

Annual Income Statements for Sherwin-Williams

This table shows Sherwin-Williams' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1,054 1,133 1,728 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Consolidated Net Income / (Loss)		 1,054 1,133 1,728 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Net Income / (Loss) Continuing Operations		 1,054 1,133 1,770 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Total Pre-Tax Income 		1,549 1,595 1,469 1,360 1,982 2,519 2,249 2,573 3,110 3,452 3,338
Total Operating Income		 1,646 1,745 1,712 2,067 2,326 2,861 2,559 3,003 3,568 3,812 3,813
Total Gross Profit		 5,560 5,921 6,719 7,419 8,036 8,683 8,543 9,325 10,758 11,195 11,516
Total Revenue		 11,339 11,856 14,984 17,535 17,901 18,362 19,945 22,149 23,052 23,099 23,574
Operating Revenue		 11,339 11,856 14,984 17,535 17,901 18,362 19,945 22,149 23,052 23,099 23,574
Total Cost of Revenue		 5,780 5,934 8,265 10,116 9,865 9,679 11,402 12,824 12,294 11,903 12,059
Operating Cost of Revenue		 5,780 5,934 8,265 10,116 9,865 9,679 11,402 12,824 12,294 11,903 12,059
Total Operating Expenses		 3,914 4,176 5,006 5,352 5,710 5,821 5,984 6,322 7,190 7,383 7,703
Selling, General & Admin Expense		 3,886 4,140 4,798 5,034 5,275 5,478 5,882 6,332 7,065 7,422 7,695
Other Operating Expenses / (Income)		 - - - - - 28 102 -25 67 -39 -10
Impairment Charge		 0.00 11 2.00 0.00 122 2.30 0.00 16 58 0.00 18
Total Other Income / (Expense), net		 -97 -150 -243 -707 -345 -342 -310 -430 -458 -360 -475
Interest Expense		 62 154 264 367 349 340 335 391 418 416 465
Interest & Investment Income		 1.40 4.96 8.60 5.20 26 3.60 4.90 8.00 25 11 11
Other Income / (Expense), net		 -36 -0.55 12 -346 -21 -5.30 20 -47 -66 45 -21
Income Tax Expense		 495 463 -300 251 441 489 384 553 721 770 770
Basic Earnings per Share		 $11.43 $12.33 $18.60 $11.92 $5.60 $7.48 $7.10 $7.83 $9.35 $10.68 $10.37
Weighted Average Basic Shares Outstanding		 92.20M 91.84M 92.90M 92.99M 275.40M 271.30M 262.50M 258M 255.40M 251M 247.60M
Diluted Earnings per Share		 $11.15 $11.99 $18.20 $11.67 $5.50 $7.36 $6.98 $7.72 $9.25 $10.55 $10.26
Weighted Average Diluted Shares Outstanding		 92.20M 91.84M 92.90M 94.99M 280.30M 275.80M 267.10M 261.80M 258.30M 254.10M 250.40M
Weighted Average Basic & Diluted Shares Outstanding		 92.20M 91.84M 92.90M 93M 92.23M 89.60M 260.37M 258.44M 254.46M 251.36M 247.77M
Cash Dividends to Common per Share		 $2.68 $3.36 $3.40 $3.44 $1.51 $1.79 $2.20 $2.40 $2.42 $2.86 $3.16

Quarterly Income Statements for Sherwin-Williams

This table shows Sherwin-Williams' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 762 356 505 890 806 480 504 755 833 477 535
Consolidated Net Income / (Loss)		 762 356 505 890 806 480 504 755 833 477 535
Net Income / (Loss) Continuing Operations		 762 356 505 890 806 480 504 755 833 477 535
Total Pre-Tax Income 		1,009 474 640 1,173 1,023 616 653 986 1,061 639 680
Total Operating Income		 1,098 642 729 1,251 1,133 698 756 1,100 1,177 779 805
Total Gross Profit		 2,916 2,549 2,531 3,063 3,028 2,573 2,559 3,118 3,126 2,713 2,781
Total Revenue		 6,117 5,252 5,367 6,272 6,163 5,297 5,306 6,315 6,358 5,596 5,667
Operating Revenue		 6,117 5,252 5,367 6,272 6,163 5,297 5,306 6,315 6,358 5,596 5,667
Total Cost of Revenue		 3,201 2,704 2,836 3,208 3,135 2,724 2,747 3,196 3,233 2,883 2,886
Operating Cost of Revenue		 3,201 2,704 2,836 3,208 3,135 2,724 2,747 3,196 3,233 2,883 2,886
Total Operating Expenses		 1,818 1,907 1,802 1,812 1,894 1,875 1,803 2,018 1,948 1,934 1,976
Selling, General & Admin Expense		 1,757 1,856 1,800 1,846 1,894 1,883 1,794 2,012 1,953 1,937 1,970
Other Operating Expenses / (Income)		 62 27 2.00 -34 0.70 -7.90 8.90 6.30 -4.70 -21 6.30
Total Other Income / (Expense), net		 -89 -168 -89 -78 -110 -83 -103 -115 -117 -140 -125
Interest Expense		 102 95 103 111 103 99 104 112 117 132 132
Interest & Investment Income		 5.10 9.40 6.10 0.90 2.60 1.40 3.30 2.40 2.60 2.90 2.80
Other Income / (Expense), net		 8.00 -83 7.70 32 -9.50 15 -2.90 -4.70 -2.30 -11 4.00
Income Tax Expense		 248 118 135 284 217 136 149 231 227 162 145
Basic Earnings per Share		 $2.98 $1.41 $2.00 $3.55 $3.22 $1.91 $2.02 $3.04 $3.38 $1.93 $2.18
Weighted Average Basic Shares Outstanding		 255.10M 255.40M 252.50M 251M 250.60M 251M 249.40M 248.40M 246.20M 247.60M 245.70M
Diluted Earnings per Share		 $2.95 $1.39 $1.97 $3.50 $3.18 $1.90 $2.00 $3.00 $3.35 $1.91 $2.15
Weighted Average Diluted Shares Outstanding		 258.40M 258.30M 255.80M 254.20M 253.90M 254.10M 252.50M 251.30M 249M 250.40M 248.10M
Weighted Average Basic & Diluted Shares Outstanding		 255.97M 254.46M 253.55M 252.26M 251.85M 251.36M 250.60M 249.33M 247.89M 247.77M 246.64M
Cash Dividends to Common per Share		 $0.61 - $0.72 $0.72 - - $0.79 $0.79 - - $0.80

Annual Cash Flow Statements for Sherwin-Williams

This table details how cash moves in and out of Sherwin-Williams' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 165 684 -649 -49 6.30 65 -61 33 78 -66 -3.20
Net Cash From Operating Activities		 1,447 1,309 1,884 1,944 2,321 3,409 2,245 1,920 3,522 3,153 3,452
Net Cash From Continuing Operating Activities		 1,447 1,309 1,884 1,944 2,321 3,409 2,245 1,920 3,522 3,153 3,452
Net Income / (Loss) Continuing Operations		 1,054 1,133 1,770 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Consolidated Net Income / (Loss)		 1,054 1,133 1,728 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Depreciation Expense		 170 172 285 278 262 268 263 264 292 297 340
Amortization Expense		 31 89 329 330 322 405 363 356 396 402 441
Non-Cash Adjustments To Reconcile Net Income		 176 168 235 348 758 490 568 587 591 514 708
Changes in Operating Assets and Liabilities, net		 16 -253 -734 -122 -562 215 -814 -1,307 -146 -741 -605
Net Cash From Investing Activities		 -289 -304 -9,047 -252 -463 -322 -476 -1,608 -1,039 -1,196 -2,066
Net Cash From Continuing Investing Activities		 -289 -304 -9,047 -252 -463 -322 -476 -1,608 -1,039 -1,196 -2,066
Purchase of Property, Plant & Equipment		 -234 -239 -223 -251 -329 -304 -372 -645 -888 -1,070 -798
Acquisitions		 0.00 0.00 -8,810 0.00 -77 0.00 -211 -1,003 -265 -79 -1,211
Sale of Property, Plant & Equipment		 11 38 47 38 6.90 61 15 33 70 12 11
Divestitures		 - - - - 0.00 0.00 123 0.00 104 0.00 0.00
Other Investing Activities, net		 -66 -103 -62 -39 -63 -79 -31 6.80 -60 -59 -68
Net Cash From Financing Activities		 -980 -307 6,514 -1,747 -1,846 -3,020 -1,834 -282 -2,425 -2,017 -1,379
Net Cash From Continuing Financing Activities		 -980 -307 6,514 -1,747 -1,846 -3,020 -1,834 -282 -2,425 -2,017 -1,379
Repayment of Debt		 -673 -83 -1,942 -1,159 -2,134 -1,450 306 -77 -787 -890 -613
Repurchase of Common Equity		 -1,035 0.00 0.00 -613 -779 -2,446 -2,752 -883 -1,432 -1,739 -1,656
Payment of Dividends		 -250 -312 -319 -323 -421 -488 -587 -619 -624 -723 -790
Issuance of Debt		 798 0.50 8,632 32 1,333 999 995 1,000 0.00 849 1,499
Other Financing Activities, net		 180 87 144 316 155 183 193 275 418 486 181
Effect of Exchange Rate Changes		 -13 -13 - 5.90 -6.00 -1.30 4.90 3.20 20 -6.20 -9.90
Cash Interest Paid		 49 154 221 368 336 341 339 371 417 407 453
Cash Income Taxes Paid		 335 478 420 292 408 437 466 580 817 780 593

Quarterly Cash Flow Statements for Sherwin-Williams

This table details how cash moves in and out of Sherwin-Williams' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 294 -227 -97 20 38 -28 -11 70 -28 -34 9.70
Net Cash From Operating Activities		 1,309 919 -59 1,203 1,075 935 -61 1,113 1,308 1,093 139
Net Cash From Continuing Operating Activities		 1,309 919 -59 1,203 1,075 935 -61 1,113 1,308 1,093 139
Net Income / (Loss) Continuing Operations		 762 356 505 890 806 480 504 755 833 477 535
Consolidated Net Income / (Loss)		 762 356 505 890 806 480 504 755 833 477 535
Depreciation Expense		 72 74 71 72 74 80 80 79 83 98 98
Amortization Expense		 104 85 102 104 95 101 110 112 108 111 120
Non-Cash Adjustments To Reconcile Net Income		 133 190 127 122 133 132 140 170 121 276 153
Changes in Operating Assets and Liabilities, net		 239 214 -864 16 -34 142 -895 -3.50 163 130 -767
Net Cash From Investing Activities		 -91 -530 -321 -261 -329 -286 -316 -241 -1,337 -172 -171
Net Cash From Continuing Investing Activities		 -91 -530 -321 -261 -329 -286 -316 -241 -1,337 -172 -171
Purchase of Property, Plant & Equipment		 -153 -320 -284 -251 -235 -300 -189 -182 -196 -230 -138
Acquisitions		 - -242 0.00 - - -79 -82 -39 2.10 -1,092 0.00
Other Investing Activities, net		 -11 9.60 -38 -19 -93 91 -45 -21 -1,143 1,140 -32
Net Cash From Financing Activities		 -916 -640 290 -917 -719 -671 367 -810 6.50 -942 48
Net Cash From Continuing Financing Activities		 -916 -640 290 -917 -719 -671 367 -810 6.50 -942 48
Repayment of Debt		 -468 -123 -20 479 -1,089 -260 -283 -26 -837 534 -408
Repurchase of Common Equity		 -410 -486 -546 -434 -449 -310 -352 -519 -668 -118 -576
Payment of Dividends		 -156 -155 -183 -179 -183 -180 -200 -198 -196 -196 -197
Issuance of Debt		 - - 883 - - - 1,136 -92 1,640 -1,184 1,181
Other Financing Activities, net		 118 124 155 99 153 80 67 24 68 22 48
Effect of Exchange Rate Changes		 -8.10 25 -6.30 -4.60 11 -6.00 -0.50 8.50 -5.00 -13 -6.50
Cash Interest Paid		 104 92 108 106 109 85 120 100 124 110 160
Cash Income Taxes Paid		 217 294 70 173 355 182 90 230 139 135 44

Annual Balance Sheets for Sherwin-Williams

This table presents Sherwin-Williams' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 5,779 6,753 19,900 19,134 20,496 20,402 20,667 22,594 22,954 23,633 25,902
Total Current Assets		 2,657 3,627 4,407 4,345 4,632 4,591 5,054 5,908 5,513 5,401 6,007
Cash & Equivalents		 206 890 204 156 162 227 166 199 277 210 207
Accounts Receivable		 1,114 1,231 2,105 2,019 2,089 2,078 2,352 2,564 2,468 2,389 2,791
Inventories, net		 1,019 1,068 1,743 1,815 1,890 1,804 1,927 2,627 2,330 2,288 2,318
Other Current Assets		 231 381 356 355 491 483 608 519 438 514 691
Plant, Property, & Equipment, net		 1,042 1,096 1,877 1,777 1,835 1,835 1,867 2,207 2,837 3,533 4,137
Total Noncurrent Assets		 2,080 2,029 13,615 13,013 14,029 13,976 13,746 14,479 14,605 14,699 15,757
Goodwill		 1,143 1,127 6,814 6,957 7,005 7,049 7,135 7,583 7,626 7,580 8,037
Intangible Assets		 255 255 6,002 5,202 4,735 4,471 4,002 4,002 3,881 3,533 3,966
Other Noncurrent Operating Assets		 436 422 502 584 2,290 2,455 2,610 2,894 3,098 3,585 3,754
Total Liabilities & Shareholders' Equity		 5,779 6,753 19,900 19,134 20,496 20,402 20,667 22,594 22,954 23,633 25,902
Total Liabilities		 4,911 4,874 16,252 15,404 16,373 16,791 18,230 19,492 19,239 19,581 21,303
Total Current Liabilities		 2,142 2,829 3,987 4,298 4,522 4,594 5,720 5,961 6,627 6,809 6,920
Short-Term Debt		 43 741 635 636 635 25 1,024 979 1,473 1,712 1,551
Accounts Payable		 1,158 1,035 1,792 1,799 1,876 2,118 2,403 2,437 2,315 2,253 2,354
Current Deferred & Payable Income Tax Liabilities		 81 77 80 81 86 184 160 197 197 174 187
Current Employee Benefit Liabilities		 338 398 508 505 553 753 717 785 863 843 839
Other Current Liabilities		 522 579 973 1,277 1,373 1,515 1,416 1,564 1,779 1,827 1,989
Total Noncurrent Liabilities		 2,769 2,045 12,264 11,106 11,851 12,196 12,510 13,531 12,612 12,773 14,383
Long-Term Debt		 1,907 1,211 9,886 8,708 8,051 8,267 8,591 9,591 8,378 8,177 9,321
Noncurrent Deferred & Payable Income Tax Liabilities		 139 74 1,420 1,131 970 846 768 682 683 608 765
Noncurrent Employee Benefit Liabilities		 249 250 275 258 263 276 259 139 133 121 130
Other Noncurrent Operating Liabilities		 475 509 684 1,009 2,567 2,808 2,892 3,119 3,418 3,868 4,167
Total Equity & Noncontrolling Interests		 868 1,878 3,648 3,731 4,123 3,611 2,437 3,102 3,716 4,051 4,598
Total Preferred & Common Equity		 868 1,878 3,648 3,731 4,123 3,611 2,437 3,102 3,716 4,051 4,598
Total Common Equity		 868 1,878 3,648 3,731 4,123 3,611 2,437 3,102 3,716 4,051 4,598
Common Stock		 2,446 2,605 2,841 3,015 3,272 3,581 3,884 4,055 4,285 4,669 4,288
Retained Earnings		 3,229 4,049 5,458 6,247 7,367 844 2,122 3,523 5,288 7,246 1,029
Treasury Stock		 -4,220 -4,236 -4,266 -4,901 -5,837 -97 -2,870 -3,776 -5,234 -6,989 -84
Accumulated Other Comprehensive Income / (Loss)		 -587 -540 -385 -630 -680 -718 -698 -701 -624 -875 -634

Quarterly Balance Sheets for Sherwin-Williams

This table presents Sherwin-Williams' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 23,166 23,005 22,954 23,428 23,734 23,968 23,633 24,636 25,364 26,206 26,379
Total Current Assets		 6,351 6,199 5,513 5,842 6,051 5,974 5,401 6,040 6,425 6,146 6,500
Cash & Equivalents		 209 503 277 180 200 238 210 200 270 242 217
Accounts Receivable		 3,118 2,941 2,468 2,809 3,048 2,973 2,389 2,813 3,112 3,122 3,192
Inventories, net		 2,439 2,244 2,330 2,378 2,289 2,267 2,288 2,515 2,485 2,276 2,473
Other Current Assets		 584 510 438 475 513 495 514 512 559 506 618
Plant, Property, & Equipment, net		 2,443 2,581 2,837 3,009 3,137 3,345 3,533 3,663 3,806 3,913 4,206
Total Noncurrent Assets		 14,373 14,225 14,605 14,577 14,547 14,649 14,699 14,933 15,132 16,147 15,673
Goodwill		 7,447 7,412 7,626 7,621 7,607 7,657 7,580 7,708 7,808 7,794 8,003
Intangible Assets		 3,934 3,824 3,881 3,778 3,693 3,657 3,533 3,493 3,543 3,466 3,886
Other Noncurrent Operating Assets		 2,992 2,989 3,098 3,178 3,247 3,335 3,585 3,731 3,781 4,887 3,784
Total Liabilities & Shareholders' Equity		 23,166 23,005 22,954 23,428 23,734 23,968 23,633 24,636 25,364 26,206 26,379
Total Liabilities		 19,535 19,225 19,239 19,924 19,982 19,812 19,581 20,506 20,963 21,781 21,948
Total Current Liabilities		 6,339 6,623 6,627 7,484 7,467 7,218 6,809 7,877 8,196 7,474 7,535
Short-Term Debt		 1,306 1,437 1,473 2,605 2,208 1,964 1,712 2,949 2,857 2,197 2,377
Accounts Payable		 2,490 2,425 2,315 2,454 2,494 2,538 2,253 2,513 2,570 2,442 2,603
Current Deferred & Payable Income Tax Liabilities		 308 380 197 240 347 215 174 226 256 255 272
Current Employee Benefit Liabilities		 701 768 863 560 709 726 843 567 689 709 592
Other Current Liabilities		 1,535 1,614 1,779 1,624 1,709 1,776 1,827 1,622 1,824 1,871 1,691
Total Noncurrent Liabilities		 13,196 12,601 12,612 12,441 12,516 12,594 12,773 12,629 12,766 14,308 14,413
Long-Term Debt		 9,096 8,499 8,378 8,130 8,131 8,175 8,177 7,827 7,829 9,318 9,323
Noncurrent Deferred & Payable Income Tax Liabilities		 711 648 683 666 642 632 608 586 561 657 765
Noncurrent Employee Benefit Liabilities		 139 139 133 133 133 133 121 121 121 121 132
Other Noncurrent Operating Liabilities		 3,250 3,314 3,418 3,512 3,610 3,654 3,868 4,096 4,256 4,212 4,193
Total Equity & Noncontrolling Interests		 3,631 3,780 3,716 3,504 3,752 4,156 4,051 4,130 4,401 4,425 4,431
Total Preferred & Common Equity		 3,631 3,780 3,716 3,504 3,752 4,156 4,051 4,130 4,401 4,425 4,431
Total Common Equity		 3,631 3,780 3,716 3,504 3,752 4,156 4,051 4,130 4,401 4,425 4,431
Common Stock		 4,136 4,196 4,285 4,391 4,434 4,564 4,669 4,715 4,773 4,821 4,359
Retained Earnings		 4,482 5,087 5,288 5,611 6,322 6,946 7,246 7,550 8,107 8,744 1,367
Treasury Stock		 -4,335 -4,747 -5,234 -5,793 -6,228 -6,678 -6,989 -7,362 -7,881 -8,549 -708
Accumulated Other Comprehensive Income / (Loss)		 -651 -756 -624 -705 -777 -676 -875 -773 -598 -590 -587

Annual Metrics And Ratios for Sherwin-Williams

This table displays calculated financial ratios and metrics derived from Sherwin-Williams' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 1.88% 4.55% 26.39% 17.02% 2.09% 2.57% 8.62% 11.05% 4.08% 0.20% 2.06%
EBITDA Growth		 19.02% 10.74% 16.58% -0.36% 24.03% 22.15% -9.20% 11.57% 17.19% 8.72% 0.38%
EBIT Growth		 21.97% 8.39% -1.16% -0.17% 33.93% 23.89% -9.72% 14.64% 18.48% 10.12% -1.67%
NOPAT Growth		 21.28% 10.66% 66.45% -18.28% 7.36% 27.46% -8.00% 11.12% 16.24% 8.05% -0.92%
Net Income Growth		 21.71% 7.48% 52.55% -35.84% 39.02% 31.73% -8.18% 8.35% 18.25% 12.25% -4.21%
EPS Growth		 27.14% 7.53% 51.79% -35.88% 39.02% 31.73% -5.16% 10.60% 19.82% 14.05% -2.75%
Operating Cash Flow Growth		 33.84% -9.60% 43.97% 3.17% 19.43% 46.84% -34.15% -14.47% 83.44% -10.47% 9.46%
Free Cash Flow Firm Growth		 37.14% -27.91% -1,084.87% 130.47% -23.77% 57.42% -41.66% -59.66% 279.17% -13.74% -44.46%
Invested Capital Growth		 -5.17% 12.60% 374.78% -7.49% -2.11% -7.67% 1.80% 13.35% -1.36% 3.31% 11.17%
Revenue Q/Q Growth		 0.31% 1.52% 8.68% 0.49% 0.28% 2.08% 1.39% 2.16% 0.09% 0.20% 1.28%
EBITDA Q/Q Growth		 6.54% 2.33% 5.05% -7.51% 6.13% 9.80% -6.98% 5.18% -0.87% 4.00% 1.86%
EBIT Q/Q Growth		 7.55% 1.70% -1.81% -6.76% 7.86% 8.71% -7.03% 7.62% -1.15% 4.15% 1.47%
NOPAT Q/Q Growth		 5.43% -0.28% 66.31% -33.66% -1.42% 7.34% -7.36% 8.92% 0.68% 2.06% 1.31%
Net Income Q/Q Growth		 6.60% 0.44% 60.30% -40.42% 10.60% 8.46% -5.24% 4.25% -1.24% 4.84% -0.13%
EPS Q/Q Growth		 7.31% 0.59% 59.79% -41.62% 10.60% 8.46% -7.18% 2.66% -2.43% 5.08% 0.10%
Operating Cash Flow Q/Q Growth		 31.26% -13.43% 17.69% -5.48% 6.78% 5.74% -22.48% 30.36% 8.56% 0.51% 4.80%
Free Cash Flow Firm Q/Q Growth		 26.09% -25.29% 4.52% 4.94% -17.21% 8.80% -32.11% 49.44% 16.41% 22.63% 11.68%
Invested Capital Q/Q Growth		 -7.77% 2.95% 3.57% -3.74% -0.74% -1.70% 4.70% 3.62% 0.59% -2.34% -2.78%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 49.03% 49.94% 44.84% 42.31% 44.89% 47.29% 42.83% 42.10% 46.67% 48.47% 48.85%
EBITDA Margin		 15.97% 16.92% 15.60% 13.29% 16.14% 19.22% 16.07% 16.14% 18.18% 19.72% 19.40%
Operating Margin		 14.51% 14.72% 11.43% 11.79% 13.00% 15.58% 12.83% 13.56% 15.48% 16.50% 16.17%
EBIT Margin		 14.19% 14.71% 11.51% 9.82% 12.88% 15.55% 12.93% 13.35% 15.19% 16.70% 16.09%
Profit (Net Income) Margin		 9.29% 9.55% 11.53% 6.32% 8.61% 11.06% 9.35% 9.12% 10.36% 11.61% 10.90%
Tax Burden Percent		 68.04% 71.01% 117.60% 81.54% 77.77% 80.60% 82.91% 78.51% 76.81% 77.68% 76.94%
Interest Burden Percent		 96.25% 91.45% 85.22% 79.00% 85.97% 88.21% 87.21% 87.05% 88.80% 89.51% 88.03%
Effective Tax Rate		 31.96% 28.99% -20.43% 18.46% 22.23% 19.40% 17.09% 21.49% 23.19% 22.32% 23.06%
Return on Invested Capital (ROIC)		 41.73% 44.62% 24.40% 12.54% 14.15% 18.96% 18.01% 18.59% 20.48% 21.92% 20.24%
ROIC Less NNEP Spread (ROIC-NNEP)		 37.97% 37.05% 18.52% 6.63% 11.13% 15.64% 15.07% 15.19% 16.95% 19.01% 16.65%
Return on Net Nonoperating Assets (RNNOA)		 71.32% 37.87% 38.14% 17.51% 25.10% 33.54% 43.64% 54.34% 49.59% 47.13% 39.15%
Return on Equity (ROE)		 113.05% 82.49% 62.53% 30.05% 39.25% 52.51% 61.65% 72.94% 70.07% 69.05% 59.39%
Cash Return on Invested Capital (CROIC)		 47.03% 32.77% -106.01% 20.31% 16.28% 26.94% 16.22% 6.08% 21.85% 18.67% 9.66%
Operating Return on Assets (OROA)		 28.04% 27.84% 12.94% 8.82% 11.63% 13.97% 12.56% 13.67% 15.38% 16.56% 15.31%
Return on Assets (ROA)		 18.36% 18.08% 12.97% 5.68% 7.78% 9.93% 9.08% 9.34% 10.49% 11.51% 10.37%
Return on Common Equity (ROCE)		 113.05% 82.49% 62.53% 30.05% 39.25% 52.51% 61.65% 72.94% 70.07% 69.05% 59.39%
Return on Equity Simple (ROE_SIMPLE)		 121.42% 60.30% 47.37% 29.72% 37.38% 56.23% 76.50% 65.12% 64.29% 66.19% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,120 1,239 2,062 1,685 1,809 2,306 2,122 2,358 2,740 2,961 2,934
NOPAT Margin		 9.87% 10.45% 13.76% 9.61% 10.11% 12.56% 10.64% 10.64% 11.89% 12.82% 12.44%
Net Nonoperating Expense Percent (NNEP)		 3.76% 7.57% 5.88% 5.91% 3.03% 3.32% 2.94% 3.40% 3.53% 2.91% 3.59%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 17.24% 20.20% 21.24% 18.96%
Cost of Revenue to Revenue		 50.97% 50.06% 55.16% 57.69% 55.11% 52.71% 57.17% 57.90% 53.33% 51.53% 51.15%
SG&A Expenses to Revenue		 34.27% 34.92% 32.02% 28.71% 29.47% 29.83% 29.49% 28.59% 30.65% 32.13% 32.64%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 34.52% 35.23% 33.41% 30.52% 31.90% 31.70% 30.00% 28.54% 31.19% 31.96% 32.67%
Earnings before Interest and Taxes (EBIT)		 1,609 1,744 1,724 1,721 2,305 2,856 2,578 2,956 3,502 3,857 3,792
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,811 2,006 2,338 2,330 2,889 3,529 3,205 3,576 4,190 4,556 4,573
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 25.64 12.39 9.90 9.38 12.52 17.87 36.92 19.47 21.31 21.13 17.47
Price to Tangible Book Value (P/TBV)		 0.00 46.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.96 1.96 2.41 1.99 2.88 3.51 4.51 2.73 3.43 3.71 3.41
Price to Earnings (P/E)		 21.12 20.55 20.89 31.55 33.49 31.78 48.26 29.90 33.14 31.93 31.27
Dividend Yield		 1.12% 1.34% 0.88% 0.92% 0.81% 0.75% 0.64% 1.03% 0.78% 0.84% 0.98%
Earnings Yield		 4.74% 4.87% 4.79% 3.17% 2.99% 3.15% 2.07% 3.35% 3.02% 3.13% 3.20%
Enterprise Value to Invested Capital (EV/IC)		 9.19 8.27 3.32 3.42 4.76 6.22 8.36 5.25 6.68 6.94 5.96
Enterprise Value to Revenue (EV/Rev)		 2.12 2.05 3.10 2.52 3.36 3.95 4.99 3.19 3.85 4.13 3.86
Enterprise Value to EBITDA (EV/EBITDA)		 13.25 12.13 19.85 18.96 20.82 20.57 31.03 19.79 21.18 20.92 19.90
Enterprise Value to EBIT (EV/EBIT)		 14.91 13.95 26.92 25.66 26.09 25.42 38.56 23.94 25.34 24.71 24.00
Enterprise Value to NOPAT (EV/NOPAT)		 21.43 19.64 22.51 26.21 33.24 31.48 46.86 30.02 32.38 32.18 31.01
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.58 18.60 24.64 22.72 25.91 21.30 44.29 36.86 25.20 30.22 26.36
Enterprise Value to Free Cash Flow (EV/FCFF)		 19.02 26.75 0.00 16.17 28.90 22.16 52.01 91.78 30.36 37.79 64.97
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 2.25 1.04 2.88 2.50 2.11 2.30 3.95 3.41 2.65 2.44 2.36
Long-Term Debt to Equity		 2.20 0.64 2.71 2.33 1.95 2.29 3.52 3.09 2.25 2.02 2.03
Financial Leverage		 1.88 1.02 2.06 2.64 2.26 2.14 2.90 3.58 2.93 2.48 2.35
Leverage Ratio		 6.16 4.56 4.82 5.29 5.05 5.29 6.79 7.81 6.68 6.00 5.73
Compound Leverage Factor		 5.93 4.17 4.11 4.18 4.34 4.66 5.92 6.80 5.93 5.37 5.04
Debt to Total Capital		 69.20% 50.97% 74.25% 71.47% 67.81% 69.66% 79.78% 77.31% 72.61% 70.94% 70.28%
Short-Term Debt to Total Capital		 1.51% 19.35% 4.48% 4.86% 4.95% 0.21% 8.50% 7.16% 10.86% 12.28% 10.02%
Long-Term Debt to Total Capital		 67.69% 31.62% 69.77% 66.60% 62.85% 69.45% 71.28% 70.15% 61.75% 58.66% 60.25%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 30.80% 49.03% 25.75% 28.53% 32.19% 30.34% 20.22% 22.69% 27.39% 29.06% 29.72%
Debt to EBITDA		 1.08 0.97 4.50 4.01 3.01 2.35 3.00 2.96 2.35 2.17 2.38
Net Debt to EBITDA		 0.96 0.53 4.41 3.94 2.95 2.29 2.95 2.90 2.28 2.12 2.33
Long-Term Debt to EBITDA		 1.05 0.60 4.23 3.74 2.79 2.34 2.68 2.68 2.00 1.79 2.04
Debt to NOPAT		 1.74 1.58 5.10 5.54 4.80 3.60 4.53 4.48 3.59 3.34 3.71
Net Debt to NOPAT		 1.56 0.86 5.00 5.45 4.71 3.50 4.45 4.40 3.49 3.27 3.64
Long-Term Debt to NOPAT		 1.70 0.98 4.79 5.17 4.45 3.58 4.05 4.07 3.06 2.76 3.18
Altman Z-Score		 6.49 6.45 2.78 3.04 3.65 3.73 4.44 3.49 4.24 4.50 3.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.24 1.28 1.11 1.01 1.02 1.00 0.88 0.99 0.83 0.79 0.87
Quick Ratio		 0.62 0.75 0.58 0.51 0.50 0.50 0.44 0.46 0.41 0.38 0.43
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,262 910 -8,961 2,731 2,081 3,277 1,911 771 2,924 2,522 1,401
Operating Cash Flow to CapEx		 648.97% 652.36% 1,072.89% 914.25% 720.90% 1,402.14% 628.39% 314.07% 430.39% 297.92% 438.63%
Free Cash Flow to Firm to Interest Expense		 20.42 5.90 -34.01 7.45 5.96 9.63 5.71 1.97 7.00 6.07 3.01
Operating Cash Flow to Interest Expense		 23.43 8.49 7.15 5.30 6.65 10.01 6.71 4.91 8.44 7.59 7.42
Operating Cash Flow Less CapEx to Interest Expense		 19.82 7.19 6.48 4.72 5.72 9.30 5.64 3.35 6.48 5.04 5.73
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.98 1.89 1.12 0.90 0.90 0.90 0.97 1.02 1.01 0.99 0.95
Accounts Receivable Turnover		 10.10 10.11 8.98 8.50 8.72 8.81 9.00 9.01 9.16 9.51 9.10
Inventory Turnover		 5.63 5.69 5.88 5.69 5.33 5.24 6.11 5.63 4.96 5.16 5.24
Fixed Asset Turnover		 10.99 11.09 10.08 9.60 9.91 10.01 10.78 10.87 9.14 7.25 6.15
Accounts Payable Turnover		 5.25 5.41 5.85 5.63 5.37 4.85 5.04 5.30 5.17 5.21 5.23
Days Sales Outstanding (DSO)		 36.13 36.10 40.63 42.92 41.88 41.42 40.54 40.51 39.83 38.37 40.10
Days Inventory Outstanding (DIO)		 64.80 64.18 62.07 64.19 68.54 69.64 59.72 64.81 73.58 70.80 69.71
Days Payable Outstanding (DPO)		 69.46 67.42 62.40 64.78 68.00 75.31 72.36 68.87 70.54 70.04 69.73
Cash Conversion Cycle (CCC)		 31.47 32.86 40.29 42.32 42.42 35.75 27.90 36.44 42.87 39.13 40.08
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,612 2,941 13,964 12,919 12,647 11,676 11,887 13,473 13,290 13,729 15,262
Invested Capital Turnover		 4.23 4.27 1.77 1.30 1.40 1.51 1.69 1.75 1.72 1.71 1.63
Increase / (Decrease) in Invested Capital		 -142 329 11,023 -1,045 -272 -970 210 1,587 -183 439 1,533
Enterprise Value (EV)		 23,998 24,334 46,415 44,163 60,144 72,595 99,423 70,762 88,746 95,290 90,989
Market Capitalization		 22,254 23,272 36,099 34,975 51,620 64,530 89,974 60,392 79,172 85,612 80,325
Book Value per Share		 $9.32 $20.22 $39.01 $39.85 $44.67 $39.76 $9.30 $11.97 $14.52 $16.09 $18.55
Tangible Book Value per Share		 ($5.70) $5.34 ($98.05) ($90.01) ($82.51) ($87.09) ($33.18) ($32.74) ($30.44) ($28.04) ($29.87)
Total Capital		 2,818 3,831 14,169 13,074 12,809 11,903 12,052 13,672 13,567 13,940 15,470
Total Debt		 1,950 1,953 10,521 9,344 8,685 8,292 9,615 10,570 9,851 9,888 10,871
Total Long-Term Debt		 1,907 1,211 9,886 8,708 8,051 8,267 8,591 9,591 8,378 8,177 9,321
Net Debt		 1,744 1,063 10,316 9,188 8,523 8,066 9,449 10,371 9,574 9,678 10,664
Capital Expenditures (CapEx)		 223 201 176 213 322 243 357 611 818 1,058 787
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 352 650 851 527 583 -204 193 727 82 93 431
Debt-free Net Working Capital (DFNWC)		 558 1,539 1,055 682 744 22 358 926 359 304 638
Net Working Capital (NWC)		 515 798 420 47 110 -3.00 -666 -53 -1,114 -1,408 -913
Net Nonoperating Expense (NNE)		 66 106 334 576 268 276 257 337 352 280 365
Net Nonoperating Obligations (NNO)		 1,744 1,063 10,316 9,188 8,523 8,066 9,449 10,371 9,574 9,678 10,664
Total Depreciation and Amortization (D&A)		 202 261 614 608 584 673 626 620 688 699 781
Debt-free, Cash-free Net Working Capital to Revenue		 3.11% 5.48% 5.68% 3.00% 3.25% -1.11% 0.97% 3.28% 0.36% 0.40% 1.83%
Debt-free Net Working Capital to Revenue		 4.92% 12.98% 7.04% 3.89% 4.16% 0.12% 1.80% 4.18% 1.56% 1.31% 2.71%
Net Working Capital to Revenue		 4.54% 6.73% 2.80% 0.27% 0.61% -0.02% -3.34% -0.24% -4.83% -6.10% -3.87%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.79 $4.11 $6.36 $3.97 $5.60 $7.48 $7.10 $7.83 $9.35 $10.68 $10.37
Adjusted Weighted Average Basic Shares Outstanding		 276.81M 279.92M 281.98M 278.15M 276.68M 271.28M 262.50M 258M 255.40M 251M 247.60M
Adjusted Diluted Earnings per Share		 $3.72 $4.00 $6.22 $3.89 $5.50 $7.36 $6.98 $7.72 $9.25 $10.55 $10.26
Adjusted Weighted Average Diluted Shares Outstanding		 276.81M 279.92M 281.98M 278.15M 276.68M 275.83M 267.10M 261.80M 258.30M 254.10M 250.40M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 276.81M 279.92M 281.98M 278.15M 276.68M 268.81M 260.37M 258.44M 254.46M 251.36M 247.77M
Normalized Net Operating Profit after Tax (NOPAT)		 1,120 1,247 1,200 1,685 1,904 2,308 2,122 2,370 2,785 2,961 2,947
Normalized NOPAT Margin		 9.87% 10.51% 8.01% 9.61% 10.64% 12.57% 10.64% 10.70% 12.08% 12.82% 12.50%
Pre Tax Income Margin		 13.66% 13.46% 9.81% 7.75% 11.07% 13.72% 11.27% 11.62% 13.49% 14.94% 14.16%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 26.05 11.32 6.54 4.69 6.60 8.39 7.70 7.56 8.39 9.28 8.15
NOPAT to Interest Expense		 18.12 8.04 7.83 4.60 5.18 6.77 6.34 6.03 6.56 7.12 6.31
EBIT Less CapEx to Interest Expense		 22.44 10.02 5.88 4.11 5.68 7.68 6.64 6.00 6.43 6.73 6.46
NOPAT Less CapEx to Interest Expense		 14.51 6.74 7.16 4.02 4.26 6.06 5.27 4.47 4.60 4.58 4.62
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 23.69% 27.55% 18.46% 29.12% 27.30% 24.03% 31.49% 30.62% 26.11% 26.98% 30.75%
Augmented Payout Ratio		 121.93% 27.55% 18.46% 84.44% 77.83% 144.52% 179.11% 74.34% 86.06% 91.83% 95.24%

Quarterly Metrics And Ratios for Sherwin-Williams

This table displays calculated financial ratios and metrics derived from Sherwin-Williams' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 246,635,621.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 246,635,621.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 2.17
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 1.15% 0.41% -1.38% 0.50% 0.75% 0.86% -1.15% 0.69% 3.18% 5.64% 6.81%
EBITDA Growth		 13.57% -4.86% 1.80% 12.60% 0.86% 24.35% 3.61% -11.78% 5.62% 9.36% 8.88%
EBIT Growth		 13.32% -6.80% 2.26% 14.93% 1.61% 27.45% 2.25% -14.62% 4.58% 7.72% 7.31%
NOPAT Growth		 6.73% 3.47% 3.33% 8.94% 7.80% 12.92% 1.40% -11.22% 3.56% 6.71% 8.42%
Net Income Growth		 11.15% -7.79% 5.82% 12.12% 5.87% 34.78% -0.26% -15.19% 3.34% -0.69% 6.11%
EPS Growth		 12.60% -7.33% 7.07% 14.01% 7.80% 36.69% 1.52% -14.29% 5.35% 0.53% 7.50%
Operating Cash Flow Growth		 104.74% 43.31% -166.78% -0.29% -17.88% 1.73% -3.74% -7.51% 21.67% 16.91% 327.66%
Free Cash Flow Firm Growth		 170.83% 159.38% 154.84% 303.20% -92.21% -84.19% -110.59% -109.56% -1,588.87% -1,004.93% -793.24%
Invested Capital Growth		 1.62% -1.36% -0.23% 0.49% 6.40% 3.31% 4.61% 6.67% 11.68% 11.17% 8.21%
Revenue Q/Q Growth		 -1.99% -14.13% 2.19% 16.85% -1.74% -14.04% 0.16% 19.01% 0.69% -11.99% 1.27%
EBITDA Q/Q Growth		 -1.07% -43.94% 26.66% 60.28% -11.39% -30.88% 5.54% 36.48% 6.09% -28.44% 5.08%
EBIT Q/Q Growth		 -0.97% -49.43% 31.78% 74.15% -12.44% -36.57% 5.72% 45.41% 7.25% -34.67% 5.33%
NOPAT Q/Q Growth		 -4.89% -41.80% 19.37% 64.86% -5.88% -39.03% 7.19% 44.34% 9.78% -37.18% 8.92%
Net Income Q/Q Growth		 -4.06% -53.22% 41.83% 76.15% -9.41% -40.45% 4.96% 49.77% 10.39% -42.77% 12.14%
EPS Q/Q Growth		 -3.91% -52.88% 41.73% 77.67% -9.14% -40.25% 5.26% 50.00% 11.67% -42.99% 12.57%
Operating Cash Flow Q/Q Growth		 8.48% -29.81% -106.41% 2,142.28% -10.66% -13.05% -106.54% 1,920.95% 17.53% -16.45% -87.27%
Free Cash Flow Firm Q/Q Growth		 242.44% 7.67% -8.72% 45.14% -94.54% 118.56% -161.12% -31.05% -750.46% -32.84% 39.67%
Invested Capital Q/Q Growth		 -4.42% 0.59% 5.78% -1.20% 1.20% -2.34% 7.12% 0.75% 5.95% -2.78% 4.27%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.68% 48.53% 47.16% 48.85% 49.13% 48.58% 48.23% 49.38% 49.16% 48.47% 49.07%
EBITDA Margin		 20.96% 13.68% 16.96% 23.26% 20.98% 16.87% 17.78% 20.38% 21.48% 17.46% 18.12%
Operating Margin		 17.95% 12.22% 13.59% 19.95% 18.39% 13.18% 14.26% 17.43% 18.52% 13.92% 14.20%
EBIT Margin		 18.08% 10.65% 13.73% 20.46% 18.23% 13.45% 14.20% 17.35% 18.48% 13.72% 14.27%
Profit (Net Income) Margin		 12.45% 6.78% 9.41% 14.19% 13.08% 9.06% 9.50% 11.95% 13.10% 8.52% 9.44%
Tax Burden Percent		 75.47% 75.15% 78.94% 75.84% 78.82% 77.99% 77.17% 76.56% 78.56% 74.62% 78.66%
Interest Burden Percent		 91.25% 84.76% 86.85% 91.44% 91.03% 86.38% 86.66% 89.96% 90.25% 83.24% 84.07%
Effective Tax Rate		 24.53% 24.85% 21.06% 24.16% 21.18% 22.01% 22.83% 23.44% 21.44% 25.38% 21.34%
Return on Invested Capital (ROIC)		 23.80% 15.82% 17.51% 25.12% 24.50% 17.58% 17.62% 21.45% 22.76% 16.89% 17.46%
ROIC Less NNEP Spread (ROIC-NNEP)		 23.12% 14.55% 16.85% 24.54% 23.60% 16.91% 16.87% 20.60% 21.89% 15.86% 16.57%
Return on Net Nonoperating Assets (RNNOA)		 71.92% 42.57% 54.26% 67.59% 57.51% 41.91% 46.69% 51.94% 54.02% 37.30% 42.69%
Return on Equity (ROE)		 95.72% 58.39% 71.77% 92.71% 82.01% 59.48% 64.31% 73.39% 76.77% 54.19% 60.15%
Cash Return on Invested Capital (CROIC)		 19.16% 21.85% 19.83% 19.98% 15.08% 18.67% 16.14% 13.50% 8.43% 9.66% 11.59%
Operating Return on Assets (OROA)		 18.40% 10.78% 13.55% 20.08% 17.90% 13.34% 13.61% 16.31% 17.15% 13.06% 13.39%
Return on Assets (ROA)		 12.67% 6.86% 9.29% 13.92% 12.84% 8.99% 9.10% 11.24% 12.16% 8.11% 8.85%
Return on Common Equity (ROCE)		 95.72% 58.39% 71.77% 92.71% 82.01% 59.48% 64.31% 73.39% 76.77% 54.19% 60.15%
Return on Equity Simple (ROE_SIMPLE)		 63.99% 0.00% 68.97% 66.98% 61.54% 0.00% 64.89% 57.83% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 829 482 576 949 893 545 584 843 925 581 633
NOPAT Margin		 13.55% 9.18% 10.72% 15.13% 14.49% 10.28% 11.00% 13.34% 14.55% 10.38% 11.17%
Net Nonoperating Expense Percent (NNEP)		 0.68% 1.26% 0.66% 0.58% 0.90% 0.67% 0.76% 0.85% 0.87% 1.02% 0.89%
Return On Investment Capital (ROIC_SIMPLE)		 - 3.55% - - - 3.91% 3.92% 5.58% 5.80% 3.76% 3.92%
Cost of Revenue to Revenue		 52.32% 51.47% 52.84% 51.15% 50.87% 51.42% 51.77% 50.62% 50.84% 51.53% 50.93%
SG&A Expenses to Revenue		 28.72% 35.34% 33.53% 29.43% 30.73% 35.55% 33.81% 31.86% 30.71% 34.61% 34.76%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 29.73% 36.31% 33.57% 28.89% 30.74% 35.40% 33.98% 31.96% 30.64% 34.56% 34.87%
Earnings before Interest and Taxes (EBIT)		 1,106 559 737 1,283 1,124 713 754 1,096 1,175 768 809
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,282 719 910 1,459 1,293 894 943 1,287 1,366 977 1,027
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 17.20 21.31 25.27 20.13 23.17 21.13 21.25 19.55 19.51 17.47 17.92
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.82 3.43 3.85 3.28 4.18 3.71 3.81 3.73 3.71 3.41 3.32
Price to Earnings (P/E)		 26.88 33.14 36.63 30.05 37.65 31.93 32.75 33.81 33.57 31.27 30.56
Dividend Yield		 0.96% 0.78% 0.73% 0.89% 0.72% 0.84% 0.84% 0.88% 0.89% 0.98% 0.99%
Earnings Yield		 3.72% 3.02% 2.73% 3.33% 2.66% 3.13% 3.05% 2.96% 2.98% 3.20% 3.27%
Enterprise Value to Invested Capital (EV/IC)		 5.63 6.68 7.05 6.17 7.55 6.94 6.69 6.51 6.22 5.96 5.71
Enterprise Value to Revenue (EV/Rev)		 3.23 3.85 4.31 3.72 4.61 4.13 4.27 4.18 4.19 3.86 3.80
Enterprise Value to EBITDA (EV/EBITDA)		 17.61 21.18 23.56 19.60 24.24 20.92 21.43 21.84 21.74 19.90 19.52
Enterprise Value to EBIT (EV/EBIT)		 21.01 25.34 28.16 23.24 28.67 24.71 25.39 26.17 26.12 24.00 23.63
Enterprise Value to NOPAT (EV/NOPAT)		 27.35 32.38 35.91 30.21 36.60 32.18 33.12 33.68 33.71 31.01 30.48
Enterprise Value to Operating Cash Flow (EV/OCF)		 22.95 25.20 29.36 25.41 33.84 30.22 31.21 31.52 29.64 26.36 24.89
Enterprise Value to Free Cash Flow (EV/FCFF)		 29.64 30.36 35.50 30.94 51.63 37.79 42.36 49.79 77.83 64.97 51.21
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 2.63 2.65 3.06 2.76 2.44 2.44 2.61 2.43 2.60 2.36 2.64
Long-Term Debt to Equity		 2.25 2.25 2.32 2.17 1.97 2.02 1.90 1.78 2.11 2.03 2.10
Financial Leverage		 3.11 2.93 3.22 2.75 2.44 2.48 2.77 2.52 2.47 2.35 2.58
Leverage Ratio		 7.10 6.68 6.98 6.35 5.92 6.00 6.30 6.02 5.85 5.73 5.96
Compound Leverage Factor		 6.47 5.66 6.06 5.81 5.39 5.18 5.46 5.42 5.28 4.77 5.01
Debt to Total Capital		 72.44% 72.61% 75.39% 73.37% 70.93% 70.94% 72.29% 70.83% 72.24% 70.28% 72.53%
Short-Term Debt to Total Capital		 10.48% 10.86% 18.30% 15.67% 13.74% 12.28% 19.79% 18.94% 13.78% 10.02% 14.73%
Long-Term Debt to Total Capital		 61.97% 61.75% 57.09% 57.70% 57.19% 58.66% 52.51% 51.89% 58.45% 60.25% 57.80%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 27.56% 27.39% 24.61% 26.63% 29.07% 29.06% 27.71% 29.17% 27.76% 29.72% 27.47%
Debt to EBITDA		 2.35 2.35 2.55 2.37 2.31 2.17 2.35 2.42 2.57 2.38 2.51
Net Debt to EBITDA		 2.23 2.28 2.51 2.32 2.26 2.12 2.31 2.36 2.51 2.33 2.47
Long-Term Debt to EBITDA		 2.01 2.00 1.93 1.86 1.87 1.79 1.71 1.77 2.08 2.04 2.00
Debt to NOPAT		 3.65 3.59 3.89 3.65 3.49 3.34 3.63 3.73 3.98 3.71 3.92
Net Debt to NOPAT		 3.47 3.49 3.83 3.58 3.41 3.27 3.56 3.64 3.89 3.64 3.85
Long-Term Debt to NOPAT		 3.12 3.06 2.95 2.87 2.82 2.76 2.64 2.73 3.22 3.18 3.13
Altman Z-Score		 3.48 3.82 4.00 3.72 4.38 4.06 3.94 3.88 3.82 3.28 3.21
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.94 0.83 0.78 0.81 0.83 0.79 0.77 0.78 0.82 0.87 0.86
Quick Ratio		 0.52 0.41 0.40 0.44 0.44 0.38 0.38 0.41 0.45 0.43 0.45
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 618 665 607 881 48 105 -64 -84 -717 -952 -574
Operating Cash Flow to CapEx		 866.12% 307.84% -20.75% 479.43% 456.74% 313.91% -32.28% 613.00% 665.78% 497.27% 100.58%
Free Cash Flow to Firm to Interest Expense		 6.06 7.03 5.90 7.96 0.47 1.07 -0.62 -0.75 -6.12 -7.24 -4.37
Operating Cash Flow to Interest Expense		 12.84 9.71 -0.57 10.86 10.39 9.49 -0.59 9.90 11.16 8.30 1.06
Operating Cash Flow Less CapEx to Interest Expense		 11.36 6.56 -3.33 8.59 8.12 6.47 -2.41 8.28 9.48 6.63 0.01
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.02 1.01 0.99 0.98 0.98 0.99 0.96 0.94 0.93 0.95 0.94
Accounts Receivable Turnover		 7.89 9.16 8.04 7.46 7.80 9.51 8.20 7.49 7.64 9.10 7.97
Inventory Turnover		 5.25 4.96 4.76 5.05 5.27 5.16 4.83 4.94 5.24 5.24 4.89
Fixed Asset Turnover		 9.97 9.14 8.56 8.25 7.78 7.25 6.91 6.65 6.41 6.15 6.08
Accounts Payable Turnover		 4.81 5.17 4.88 4.80 4.79 5.21 4.76 4.66 4.78 5.23 4.77
Days Sales Outstanding (DSO)		 46.27 39.83 45.42 48.91 46.82 38.37 44.54 48.71 47.80 40.10 45.79
Days Inventory Outstanding (DIO)		 69.48 73.58 76.65 72.22 69.29 70.80 75.59 73.82 69.69 69.71 74.63
Days Payable Outstanding (DPO)		 75.88 70.54 74.87 76.12 76.22 70.04 76.73 78.31 76.37 69.73 76.54
Cash Conversion Cycle (CCC)		 39.87 42.87 47.20 45.01 39.90 39.13 43.40 44.22 41.11 40.08 43.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 13,213 13,290 14,059 13,891 14,058 13,729 14,707 14,817 15,699 15,262 15,914
Invested Capital Turnover		 1.76 1.72 1.63 1.66 1.69 1.71 1.60 1.61 1.56 1.63 1.56
Increase / (Decrease) in Invested Capital		 211 -183 -32 68 845 439 648 927 1,642 1,533 1,207
Enterprise Value (EV)		 74,444 88,746 99,081 85,654 106,181 95,290 98,350 96,463 97,608 90,989 90,907
Market Capitalization		 65,012 79,172 88,526 75,515 96,279 85,612 87,774 86,046 86,334 80,325 79,424
Book Value per Share		 $14.70 $14.52 $13.88 $14.80 $16.48 $16.09 $16.43 $17.56 $17.75 $18.55 $17.88
Tangible Book Value per Share		 ($29.00) ($30.44) ($31.27) ($29.77) ($28.38) ($28.04) ($28.13) ($27.73) ($27.41) ($29.87) ($30.10)
Total Capital		 13,716 13,567 14,239 14,091 14,296 13,940 14,907 15,087 15,941 15,470 16,131
Total Debt		 9,936 9,851 10,735 10,339 10,140 9,888 10,776 10,686 11,516 10,871 11,700
Total Long-Term Debt		 8,499 8,378 8,130 8,131 8,175 8,177 7,827 7,829 9,318 9,321 9,323
Net Debt		 9,433 9,574 10,555 10,139 9,902 9,678 10,577 10,417 11,274 10,664 11,483
Capital Expenditures (CapEx)		 151 298 284 251 235 298 189 182 196 220 138
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 509 82 784 592 482 93 913 817 629 431 1,125
Debt-free Net Working Capital (DFNWC)		 1,012 359 964 792 721 304 1,112 1,086 870 638 1,342
Net Working Capital (NWC)		 -424 -1,114 -1,641 -1,416 -1,244 -1,408 -1,837 -1,771 -1,327 -913 -1,035
Net Nonoperating Expense (NNE)		 67 126 70 59 87 64 80 88 92 104 98
Net Nonoperating Obligations (NNO)		 9,433 9,574 10,555 10,139 9,902 9,678 10,577 10,417 11,274 10,664 11,483
Total Depreciation and Amortization (D&A)		 176 159 173 176 169 181 190 191 190 210 218
Debt-free, Cash-free Net Working Capital to Revenue		 2.21% 0.36% 3.41% 2.57% 2.09% 0.40% 3.96% 3.54% 2.70% 1.83% 4.70%
Debt-free Net Working Capital to Revenue		 4.40% 1.56% 4.20% 3.44% 3.13% 1.31% 4.83% 4.71% 3.74% 2.71% 5.61%
Net Working Capital to Revenue		 -1.84% -4.83% -7.14% -6.15% -5.40% -6.10% -7.97% -7.67% -5.70% -3.87% -4.32%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.98 $1.41 $2.00 $3.55 $3.22 $1.91 $2.02 $3.04 $3.38 $1.93 $2.18
Adjusted Weighted Average Basic Shares Outstanding		 255.10M 255.40M 252.50M 251M 250.60M 251M 249.40M 248.40M 246.20M 247.60M 245.70M
Adjusted Diluted Earnings per Share		 $2.95 $1.39 $1.97 $3.50 $3.18 $1.90 $2.00 $3.00 $3.35 $1.91 $2.15
Adjusted Weighted Average Diluted Shares Outstanding		 258.40M 258.30M 255.80M 254.20M 253.90M 254.10M 252.50M 251.30M 249M 250.40M 248.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 255.97M 254.46M 253.55M 252.26M 251.85M 251.36M 250.60M 249.33M 247.89M 247.77M 246.64M
Normalized Net Operating Profit after Tax (NOPAT)		 829 482 576 949 893 545 584 843 925 581 633
Normalized NOPAT Margin		 13.55% 9.18% 10.72% 15.13% 14.49% 10.28% 11.00% 13.34% 14.55% 10.38% 11.17%
Pre Tax Income Margin		 16.50% 9.02% 11.92% 18.71% 16.60% 11.62% 12.31% 15.61% 16.68% 11.42% 12.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 10.85 5.91 7.15 11.58 10.87 7.24 7.26 9.75 10.03 5.83 6.14
NOPAT to Interest Expense		 8.13 5.10 5.59 8.56 8.64 5.53 5.62 7.50 7.89 4.42 4.81
EBIT Less CapEx to Interest Expense		 9.37 2.76 4.40 9.32 8.59 4.21 5.44 8.13 8.35 4.16 5.09
NOPAT Less CapEx to Interest Expense		 6.65 1.94 2.83 6.30 6.36 2.51 3.80 5.88 6.22 2.75 3.76
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 25.80% 26.11% 26.88% 26.74% 27.33% 26.98% 27.66% 29.89% 30.09% 30.75% 30.26%
Augmented Payout Ratio		 70.37% 86.06% 96.23% 101.40% 102.19% 91.83% 85.31% 93.90% 101.97% 95.24% 102.60%

Financials Breakdown Chart

Key Financial Trends

  • Revenue has trended higher over the period, rising from about $5.25B in Q4 2023 to $5.60B in Q4 2025 (and hitting roughly $6.36B in Q3 2025 vs $6.17B in Q3 2024), indicating improving top‑line momentum.
  • Gross margin has remained stable around 48–49% across multiple quarters, suggesting persistent pricing power and solid cost control.
  • Operating cash flow remains robust and has trended higher in 2025 vs 2024 (for example, net cash from continuing operating activities was about $1.093B in Q4 2025 and about $1.308B in Q3 2025, vs lower levels in the prior year), signaling strong cash earnings.
  • Shareholder returns have continued via sizable stock buybacks and steady cash dividends (examples include substantial repurchases in several quarters, e.g., Q3 2025 around $668M; Q2 2025 around $518.5M; Q4 2025 around $118M, with a consistent quarterly cash dividend per share of $0.79 in multiple periods).
  • Total assets have expanded over time (e.g., approximately $26.2B by Q3 2025 vs around $23.0B in earlier years), supported by a growing equity base, though long‑term debt has risen as well.
  • Accounts receivable and inventories have grown in line with higher activity, indicating a modest working capital build, which is typical for a larger, expanding footprint.
  • Long‑term debt has increased (e.g., about $9.32B by Q3 2025 vs ~$7.8B in mid‑2025), reflecting leverage that may support growth and capital returns but warrants watching for interest coverage over time.
  • Net income in Q4 2025 declined slightly versus Q4 2024 (476.8M vs 480.1M), suggesting some quarterly earnings softness despite the revenue and margin strength.
  • Investing cash flow remains a use of cash in several quarters, with ongoing capital investments (for example, notable PPE purchases and acquisitions in multiple periods), which can temper near‑term free cash flow.
  • Interest expense remains a material cost (e.g., around $131M in Q4 2025 and $110–118M in other recent quarters), reflecting a debt load that could pressure margins if rates rise or if profitability tightens.
05/15/26 01:52 AM ETAI Generated. May Contain Errors.

Sherwin-Williams Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sherwin-Williams' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Sherwin-Williams' net income appears to be on an upward trend, with a most recent value of $2.57 billion in 2025, rising from $1.05 billion in 2015. The previous period was $2.68 billion in 2024. See where experts think Sherwin-Williams is headed by visiting Sherwin-Williams' forecast page.

Sherwin-Williams' total operating income in 2025 was $3.81 billion, based on the following breakdown:
  • Total Gross Profit: $11.52 billion
  • Total Operating Expenses: $7.70 billion

Over the last 10 years, Sherwin-Williams' total revenue changed from $11.34 billion in 2015 to $23.57 billion in 2025, a change of 107.9%.

Sherwin-Williams' total liabilities were at $21.30 billion at the end of 2025, a 8.8% increase from 2024, and a 333.8% increase since 2015.

In the past 10 years, Sherwin-Williams' cash and equivalents has ranged from $155.50 million in 2018 to $889.79 million in 2016, and is currently $207.20 million as of their latest financial filing in 2025.

Over the last 10 years, Sherwin-Williams' book value per share changed from 9.32 in 2015 to 18.55 in 2025, a change of 99.0%.


Related Companies

Financial statements for NYSE:SHW last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel